Amniotic membrane transplantation for infectious corneal ulcer treatment: a cohort retrospective study

  • Vega Casalita Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Rina La Distia Nora Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia https://orcid.org/0000-0002-7026-5341
  • Lukman Edwar Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia https://orcid.org/0000-0002-5484-9515
  • Made Susiyanti Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia https://orcid.org/0000-0002-9517-7137
  • Ratna Sitompul Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
DOI: https://doi.org/10.13181/mji.oa.203849
Keywords: amniotic membrane, corneal perforation, infectious keratitis
Abstract viewed: 1599 times
PDF downloaded: 876 times
HTML downloaded: 123 times
EPUB downloaded: 262 times

Abstract

BACKGROUND Corneal ulcer is one of the most common causes of corneal blindness. This study aimed to describe the outcomes of amniotic membrane transplantation (AMT) in patients with infectious corneal ulcer.

METHODS A retrospective cohort study based on medical records of patients who underwent an adjuvant AMT procedure over a 2-year period (2015–2017) was conducted at Cipto Mangunkusumo Hospital Jakarta. Uncorrected visual acuity (UCVA) was measured with the Snellen chart. Treatment success was marked by complete healing (disappearance of corneal infiltrates, epithelial defect closure, and corneal scar formation). Healing time was the duration from AMT surgery to complete healing.

RESULTS 50 cases of infectious corneal ulcer, 12 of which had perforation were included. Gram-positive cocci (18%), gram-negative rods (14%), fungi (4%), and Acanthamoeba (2%) were isolated from culture specimens. Successful results were observed in 90% of cases (20/21 moderate cases and 25/29 severe cases). Healing time was 21 (14–63) days in moderate cases and 28 (14–90) days in severe cases. Baseline UCVA improved from 2.48 (0.22–2.80) logMAR to 1.30 (0–2.80) logMAR within 3–4 weeks postoperatively and to 0.94 (0–2.80) logMAR at the last follow-up. Post-AMT complications included recurrent perforation in 4 eyes, persistent epithelial defects in 2 eyes, amniotic membrane infection in 1 eye, and membrane retraction in 1 eye.

CONCLUSIONS AMT was successfully used to treat moderate and severe infectious corneal ulcer, particularly in nonresponsive and some perforated cases. AMT provides biochemical and mechanical support for corneal wound healing with good visual outcomes.

References

  1. Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ. 2001;79(3):214-21.

  2. Darsini IP. Demographic profile, clinical characteristics and therapy of keratitis and corneal ulcers in the Ophthalmology Clinic of Infection and Immunology Kirana Cipto Mangunkusumo Hospital period of January - December; 2013. Descriptive Study. Jakarta: Universitas Indonesia; 2015.

  3. Hong AR, Shute TS, Huang AJW. Bacterial keratitis. In: Mannis MJ, Holland EJ. Cornea. 4th ed. Philadelphia: Elsevier; 2017. p. 875-901.

  4. Guell JL, Gris O, Elies D, Manero F, Morral M. Indications for and uses of amniotic membrane. In: Mannis MJ, Holland, Edward J. Cornea. 4th ed. Philadelphia: Elsevier; 2017. p. 1581-7.

  5. Rizzuti A, Goldenberg A, Lazzaro DR. Amniotic membrane allografts: development and clinical utility in ophthalmology. Chronic Wound Care Manag Res. 2014;1:67-72. https://doi.org/10.2147/CWCMR.S50955

  6. Maholtra C, Jain AK. Human amniotic membrane transplantation: different modalities of its use in ophthalmology. World J Transplant. 2014;4(2):111-21. https://doi.org/10.5500/wjt.v4.i2.111

  7. Paolin A, Cogliati E, Trojan D, Griffoni C, Grassetto A, Elbadawy HM, et al. Amniotic membranes in ophthalmology: long term data on transplantation outcomes. Cell Tissue Bank. 2016;17(1):51-8. https://doi.org/10.1007/s10561-015-9520-y

  8. Solomon A, Meller D, Prabhasawat P, John T, Espana EM, Steuhl KP, et al. Amniotic membrane grafts for nontraumatic corneal perforations, descematoceles, and deep ulcers. Ophthalmology. 2002;109(4):694-703. https://doi.org/10.1016/S0161-6420(01)01032-6

  9. Rodríguez-Ares MT, Touriño R, López-Valladares MJ, Gude F. Multilayer amniotic membrane transplantation in the treatment of corneal perforations. Cornea. 2004;23(4):577-83. https://doi.org/10.1097/01.ico.0000121709.58571.12

  10. Abdulhalim BH, Wagih MM, Gad AA, Boghdadi G, Nagy RR. Amniotic membrane graft to conjunctival flap in treatment of non-viral resistant infectious keratitis: a randomised clinical study. Br J Ophthalmol. 2015;99(1):59-63. https://doi.org/10.1136/bjophthalmol-2014-305224

  11. Chen HC, Tan HY, Hsiao CH, Huang SC, Lin KK, Ma DH. Amniotic membrane transplantation for persistent corneal ulcers and perforations in acute fungal keratitis. Cornea. 2006;25(5):564-72. https://doi.org/10.1097/01.ico.0000227885.19124.6f

  12. Fan J, Wang M, Zhong F. Improvement of amniotic membrane method for the treatment of corneal perforation. Biomed Res Int. 2016;2016:1693815. https://doi.org/10.1155/2016/1693815

  13. Tabatabaei SA, Soleimani M, Behrouz MJ, Torkashvand A, Anvari P, Yaseri M. A randomized clinical trial to evaluate the usefulness of amniotic membrane transplantation in bacterial keratitis healing. Ocul Surf. 2017;15(2):218-26. https://doi.org/10.1016/j.jtos.2017.01.004

  14. Gicquel JJ, Bejjani RA, Ellies P, Mercié M, Dighiero P. Amniotic membrane transplantation in severe bacterial keratitis. Cornea. 2007;26(1):27-33. https://doi.org/10.1097/ICO.0b013e31802b28df

  15. Altay Y, Tamer S, Burcu A, Balta Ö. Amniotic membrane transplantation in bacterial and herpetic stromal keratitis. Turk J Med Sci. 2016;46:457-62. https://doi.org/10.3906/sag-1501-6

  16. Hapsari D, Gondhowiarjo TD, Susiyanti M. Effectiveness and safety of combined therapy of superficial keratectomy with amniotic membrane transplantation and topical autologous plasma in bacterial corneal ulcer [thesis]. [Jakarta]: Universitas Indonesia; 2014.

  17. Thatte S, Choudhary U, Sharma B. Efficacy of amniotic membrane transplantation in refractory infective keratitis leading to stromal thinning, descematocele and perforations. JOJ Ophthal. 2017;3(3):555611. https://doi.org/10.19080/JOJO.2017.03.555611

  18. Kheirkhah A, Tabatabaei A, Zavareh MK, Khodabandeh A, Mohammadpour M, Raju VK. A controlled study of amniotic membrane transplantation for acute Pseudomonas keratitis. Can J Ophthalmol. 2012;47(3):305-11. https://doi.org/10.1016/j.jcjo.2012.03.014

  19. Ljubimov A, Saghizadeh M. Progress in corneal wound healing. Prog Retin Eye Res. 2015;49:17-45. https://doi.org/10.1016/j.preteyeres.2015.07.002

  20. Kang BS, Kim MK, Wee WR, Oh JY. Infectious keratitis in limbal stem cell deficiency: Stevens-Johnson syndrome versus chemical burn. Cornea. 2016;35(1):51-5. https://doi.org/10.1097/ICO.0000000000000677

Published
2020-12-30
How to Cite
1.
Casalita V, Nora RLD, Edwar L, Susiyanti M, Sitompul R. Amniotic membrane transplantation for infectious corneal ulcer treatment: a cohort retrospective study. Med J Indones [Internet]. 2020Dec.30 [cited 2024Apr.19];29(4):379-85. Available from: http://mji.ui.ac.id/journal/index.php/mji/article/view/3849
Issue
Vol. 29 No. 4 (2020): December
Section
Clinical Research

Copyright (c) 2020 vega casalita

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with Medical Journal of Indonesia agree to the following terms:

  1. Authors retain copyright and grant Medical Journal of Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Medical Journal of Indonesia.
  2. Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Medical Journal of Indonesia.

Most read articles by the same author(s)